MangoceuticalsMGRX
13F holders, Q4 2024 (December 31)9holders +8
4new positions
1sold out
$2.42avg. 13F price*
At the end of Q4 2024, 9 institutions reported holding Mangoceuticals Inc. (MGRX) in their 13F filings, up 8 from Q3 2024. 4 opened new positions and 1 sold out. The largest holders were Ackerman Capital Advisors, LLC ($83K), Virtu Financial LLC ($50K) and HRT Financial LP ($32K).
- Company
- Mangoceuticals Inc.
- CUSIP
- 56270V205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $53K |
| Exits | 1 | $4K |
All 13F filers, Q3 2024 → Q4 2024: 44,144 shares bought and 44,280 shares sold, net −136 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Ackerman Capital Advisors, LLC | 0.02% | Reduce -44.0% | 34,500 | $83K |
| Virtu Financial LLC | 0.00% | Add +1443.3% | 20,501 | $50K |
| HRT Financial LP | 0.00% | New | 13,472 | $32K |
| Geode Capital Management, LLC | 0.00% | Add +29.6% | 12,003 | $29K |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 4,600 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 2,633 | $6K |
| Steward Partners Investment Advisory, LLC | 0.00% | Reduce -5.4% | 2,094 | $5K |
| UBS Group AG | 0.00% | New | 1,524 | $4K |
| Bank of America Corp. | 0.00% | No change | 11 | $27 |
"% of holder's portfolio" is MGRX's weight in each manager's 13F, not the share of Mangoceuticals Inc. the manager owns.